{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "9460600", "DateCompleted": {"Year": "1998", "Month": "03", "Day": "12"}, "DateRevised": {"Year": "2013", "Month": "11", "Day": "21"}, "Article": {"Language": ["rus"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0869-2092", "JournalIssue": {"Volume": "60", "Issue": "6", "PubDate": {"Year": "1997", "Season": "Nov-Dec"}}, "Title": "Eksperimental'naia i klinicheskaia farmakologiia", "ISOAbbreviation": "Eksp Klin Farmakol"}, "ArticleTitle": "[Effect of Scutellaria baicalensis extract on the immunologic status of patients with lung cancer receiving antineoplastic chemotherapy].", "Pagination": {"StartPage": "49", "EndPage": "51", "MedlinePgn": "49-51"}, "Abstract": {"AbstractText": ["Cytostatic therapy of patients with lung cancer is attended with decrease in the relative number of T-lymphocytes and their theophylline-resistant population. Patients who were given SB showed a tendency towards increase of these parameters during antitumor chemotherapy. The immunoregulation index (IRI) in this case was approximately twice the background values during the whole period of investigation. The inclusion of SB in the therapeutic complex promotes increase in the number of immunoglobulins A at a stable level of immunoglobulins G."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Pharmacology Tomsk Research Center, Russian Academy of Medical Sciences, Russia."}], "LastName": "Smol'ianinov", "ForeName": "E S", "Initials": "ES"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Gol'dberg", "ForeName": "V E", "Initials": "VE"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Matiash", "ForeName": "M G", "Initials": "MG"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Ryzhakov", "ForeName": "V M", "Initials": "VM"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Boldyshev", "ForeName": "D A", "Initials": "DA"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Litvinenko", "ForeName": "V I", "Initials": "VI"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Dyga\u012d", "ForeName": "A M", "Initials": "AM"}], "PublicationTypeList": ["Clinical Trial", "English Abstract", "Journal Article"], "VernacularTitle": "Vliianie \u00e9kstracta shlemnika ba\u012dkal'skogo na immunologicheski\u012d status bol'nykh rakom legkogo v usloviiakh protivoopukholevo\u012d khimioterapii."}, "MedlineJournalInfo": {"Country": "Russia (Federation)", "MedlineTA": "Eksp Klin Farmakol", "NlmUniqueID": "9215981", "ISSNLinking": "0869-2092"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Adjuvants, Immunologic"}, {"RegistryNumber": "0", "NameOfSubstance": "Endotoxins"}, {"RegistryNumber": "0", "NameOfSubstance": "Immunoglobulin A"}, {"RegistryNumber": "0", "NameOfSubstance": "Immunoglobulin G"}, {"RegistryNumber": "80168379AG", "NameOfSubstance": "Doxorubicin"}, {"RegistryNumber": "8N3DW7272P", "NameOfSubstance": "Cyclophosphamide"}, {"RegistryNumber": "YL5FZ2Y5U1", "NameOfSubstance": "Methotrexate"}], "SupplMeshList": ["CAM combination"], "MeshHeadingList": [{"QualifierName": ["therapeutic use"], "DescriptorName": "Adjuvants, Immunologic"}, {"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": [], "DescriptorName": "Aged"}, {"QualifierName": ["adverse effects", "therapeutic use"], "DescriptorName": "Antineoplastic Combined Chemotherapy Protocols"}, {"QualifierName": ["drug effects", "immunology"], "DescriptorName": "B-Lymphocytes"}, {"QualifierName": ["administration & dosage", "adverse effects"], "DescriptorName": "Cyclophosphamide"}, {"QualifierName": ["administration & dosage", "adverse effects"], "DescriptorName": "Doxorubicin"}, {"QualifierName": [], "DescriptorName": "Endotoxins"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["blood"], "DescriptorName": "Immunoglobulin A"}, {"QualifierName": ["blood"], "DescriptorName": "Immunoglobulin G"}, {"QualifierName": ["drug therapy", "immunology", "pathology"], "DescriptorName": "Lung Neoplasms"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["administration & dosage", "adverse effects"], "DescriptorName": "Methotrexate"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": [], "DescriptorName": "Neoplasm Staging"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["drug effects", "immunology"], "DescriptorName": "T-Lymphocytes"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1998", "Month": "2", "Day": "14"}, {"Year": "1998", "Month": "2", "Day": "14", "Hour": "0", "Minute": "1"}, {"Year": "1998", "Month": "2", "Day": "14", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["9460600"]}}]}